Iron deficiency intravenous substitution in a Swiss academic primary care division: analysis of practices.

Details

Ressource 1Download: BIB_254B611C8920.P001.pdf (210.44 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_254B611C8920
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Iron deficiency intravenous substitution in a Swiss academic primary care division: analysis of practices.
Journal
International Journal of General Medicine
Author(s)
Varcher M., Zisimopoulou S., Braillard O., Favrat B., Junod Perron N.
ISSN
1178-7074 (Electronic)
ISSN-L
1178-7074
Publication state
Published
Issued date
2016
Peer-reviewed
Oui
Volume
9
Pages
221-227
Language
english
Abstract
BACKGROUND: Iron deficiency is a common problem in primary care and is usually treated with oral iron substitution. With the recent simplification of intravenous (IV) iron administration (ferric carboxymaltose) and its approval in many countries for iron deficiency, physicians may be inclined to overutilize it as a first-line substitution.
OBJECTIVE: The aim of this study was to evaluate iron deficiency management and substitution practices in an academic primary care division 5 years after ferric carboxymaltose was approved for treatment of iron deficiency in Switzerland.
METHODS: All patients treated for iron deficiency during March and April 2012 at the Geneva University Division of Primary Care were identified. Their medical files were analyzed for information, including initial ferritin value, reasons for the investigation of iron levels, suspected etiology, type of treatment initiated, and clinical and biological follow-up. Findings were assessed using an algorithm for iron deficiency management based on a literature review.
RESULTS: Out of 1,671 patients, 93 were treated for iron deficiency. Median patients' age was 40 years and 92.5% (n=86) were female. The average ferritin value was 17.2 μg/L (standard deviation 13.3 μg/L). The reasons for the investigation of iron levels were documented in 82% and the suspected etiology for iron deficiency was reported in 67%. Seventy percent of the patients received oral treatment, 14% IV treatment, and 16% both. The reasons for IV treatment as first- and second-line treatment were reported in 57% and 95%, respectively. Clinical and biological follow-up was planned in less than two-thirds of the cases.
CONCLUSION: There was no clear overutilization of IV iron substitution. However, several steps of the iron deficiency management were not optimally documented, suggesting shortcuts in clinical reasoning.
Pubmed
Web of science
Open Access
Yes
Create date
28/07/2016 13:04
Last modification date
20/08/2019 13:03
Usage data